MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s41551-025-01428-2

Медицинская библиотека · Nature biomedical engineering · 2025

Bioengineered immunocompetent preclinical trial-on-chip tool enables screening of CAR T cell therapy for leukaemia.

Ma Chao, Wang Huishu, Liu Lunan, Chen Ruiqi, Mukherjee Nandana, Tong Jie, Kazmi Shadab, Fang Xiangyi, Witkowski Matthew T, Aifantis Iannis, Ghassemi Saba, Chen Weiqiang

СтатьяПеревод пока не подготовлен

Аннотация

Chimeric antigen receptor (CAR) T cell immunotherapy is promising for treatment of blood cancers; however, clinical benefits remain unpredictable, necessitating development of optimal CAR T cell products. Unfortunately, current preclinical evaluation platforms are inadequate owing to their limited physiological relevance to humans. Here we engineer an organotypic immunocompetent chip that recapitulates microarchitectural and pathophysiological characteristics of human leukaemia bone marrow stromal and immune niches for CAR T cell therapy modelling. This leukaemia chip empowers real-time spatiotemporal monitoring of CAR T cell functionality, including T cell extravasation, recognition of leukaemia, immune activation, cytotoxicity and killing. We use our chip to model clinically observed heterogeneous responses such as remission, resistance and relapse under CAR T cell therapy and map factors that drive therapeutic success or failure. Finally, we demarcate functional performance of CAR T cells produced from different healthy donors and patients with cancer, with various CAR designs and protocols, systematically and multidimensionally. Together, our chip introduces an enabling '(pre-)clinical-trial-on-chip' tool for CAR T cell development, which may translate to personalized therapies and improved clinical decision-making.

Для цитирования: Ma Chao, Wang Huishu, Liu Lunan, Chen Ruiqi, Mukherjee Nandana, Tong Jie, Kazmi Shadab, Fang Xiangyi, Witkowski Matthew T, Aifantis Iannis, Ghassemi Saba, Chen Weiqiang. Bioengineered immunocompetent preclinical trial-on-chip tool enables screening of CAR T cell therapy for leukaemia.. Nature biomedical engineering. 2025. DOI: 10.1038/s41551-025-01428-2.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.